Search

Search Constraints

You searched for: Author/Creator Cilloni, Daniela

Search Results

1. A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy. (10th April 2013)

2. Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI). Issue 1 (2nd January 2022)

3. AVALON: The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia. Issue 7 (24th January 2023)

4. Bcl‐xL represents a therapeutic target in Philadelphia negative myeloproliferative neoplasms. Issue 18 (13th August 2020)

5. Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes. (23rd February 2016)

8. Curcumin induces apoptosis in JAK2‐mutated cells by the inhibition of JAK2/STAT and mTORC1 pathways. Issue 6 (29th April 2019)

9. Deferasirox for transfusion‐dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial). (10th April 2014)

10. Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX‐IOL study. (8th February 2022)